Growth Metrics

Elicio Therapeutics (ELTX) Equity Income (2020 - 2022)

Elicio Therapeutics posted quarterly Equity Income of $9000.0 for Q3 2022, down 70.97% year-on-year from $31000.0 in Q3 2021, and down 93.23% on a QoQ basis from $133000.0 in Q2 2022.

Elicio Therapeutics (ELTX) has 3 years of Equity Income data on file, last reported at $9000.0 in Q3 2022.

  • For the quarter ending Q3 2022, Equity Income fell 70.97% year-over-year to $9000.0; the trailing twelve-month figure through Mar 2023 stood at $142000.0 (up 192.21% YoY), and the FY2022 full-year result was $151000.0, up 257.29% from the prior year.
  • Equity Income for Q3 2022 stood at $9000.0, down from $133000.0 in the prior quarter.
  • Across five years, Equity Income topped out at $133000.0 in Q2 2022 and bottomed at -$172000.0 in Q4 2021.
  • The 3-year median for Equity Income is $18500.0 (2020), against an average of -$1600.0.
  • The widest annual swing landed in 2021, when Equity Income slumped 178.57%; it then jumped 704.55% in 2022.
  • A 3-year view of Equity Income shows it stood at -$127000.0 in 2020, then sank by 35.43% to -$172000.0 in 2021, then surged by 105.23% to $9000.0 in 2022.
  • The last three Equity Income figures came in at $9000.0 (Q3 2022), $133000.0 (Q2 2022), and $9000.0 (Q1 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 235,807.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Elicio Therapeutics 217.63 Mn 202.68 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2022 9,000.00
Jun 30, 2022 133,000.00
Mar 31, 2022 9,000.00
Dec 31, 2021 -172,000.00
Sep 30, 2021 31,000.00
Jun 30, 2021 -22,000.00
Mar 31, 2021 67,000.00
Dec 31, 2020 -127,000.00
Jun 30, 2020 28,000.00
Mar 31, 2020 28,000.00